Skip to content

Anti-HLA Antibodies After Bone Regeneration Surgery

Assessment of Anti-HLA Antibody Development After Bone Regeneration Procedures and Analysis of Healing Processes

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07474857
Acronym
Anti-HLA Bone
Enrollment
20
Registered
2026-03-16
Start date
2023-07-01
Completion date
2024-12-29
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Loss, Maxillary Sinus Bone Loss

Keywords

Sinus Lift, Bone Regeneration, Anti-HLA Antibodies, Allogeneic Bone Graft, Xenogeneic Bone Graft, Photobiomodulation, Dental Implant Therapy

Brief summary

This study evaluates the occurrence of anti-human leukocyte antigen (anti-HLA) antibodies following bone regeneration procedures performed prior to dental implant therapy. Allogeneic bone grafts are widely used in regenerative oral surgery due to their favorable osteoconductive and osteoinductive properties; however, their use may be associated with the development of anti-HLA antibodies, which could potentially influence graft integration and healing. Twenty generally healthy adult patients requiring bone augmentation procedures before implant therapy will be included in the study. Patients will receive either a xenogeneic or allogeneic bone graft material during the regenerative procedure. Additionally, half of the participants will receive adjunctive low-level laser therapy (LLLT) in the postoperative period. Blood samples will be collected before surgery and during follow-up to assess anti-HLA antibody levels. Radiological evaluation using cone-beam computed tomography (CBCT) will be performed to assess bone regeneration. After a healing period of approximately 3-6 months, bone samples will be collected during implant placement and analyzed histologically. The study aims to determine whether bone graft origin and photobiomodulation therapy influence anti-HLA antibody development and the healing of regenerated bone tissue.

Detailed description

Bone regeneration procedures are frequently required before implant-supported prosthetic rehabilitation in patients with insufficient alveolar bone volume. Allogeneic bone graft materials are widely used in oral and maxillofacial surgery because of their favorable osteoconductive properties and biological similarity to human bone. Despite these advantages, concerns have been raised regarding the possible immunological response associated with their use, including the development of anti-human leukocyte antigen (anti-HLA) antibodies. The presence of anti-HLA antibodies has been well documented in large organ and tissue transplantation procedures. However, recent reports suggest that even smaller regenerative procedures involving allogeneic bone grafts may lead to the development of these antibodies. Such immunological reactions may potentially influence graft integration, healing dynamics, and the overall regenerative outcome. The aim of this clinical study is to evaluate changes in anti-HLA antibody levels following bone regeneration procedures and to analyze their potential association with bone healing processes. In addition, the study investigates whether adjunctive photobiomodulation using low-level laser therapy (LLLT) may influence the regenerative process. The study includes twenty generally healthy adult patients who require bone augmentation prior to implant-supported rehabilitation. Patients undergo regenerative procedures involving either xenogeneic or allogeneic bone graft materials. In addition, a subgroup of participants receives postoperative photobiomodulation therapy using a diode laser. Before surgery, patients undergo clinical and radiological evaluation, including cone-beam computed tomography (CBCT), to assess the anatomical conditions and plan the surgical procedure. Blood samples are collected prior to surgery to determine baseline levels of anti-HLA antibodies. During the regenerative procedure, bone graft material is placed in the area of the bone defect under local anesthesia using standard surgical techniques. In patients allocated to photobiomodulation therapy, diode laser irradiation is applied in the postoperative period according to the study protocol. Follow-up evaluation is performed approximately three to six months after the augmentation procedure. At this stage, additional blood samples are collected to assess secondary anti-HLA antibody levels. Radiological examination using CBCT is repeated to evaluate bone regeneration parameters. During implant placement, bone core biopsies are obtained using a trephine drill to allow histological assessment of regenerated bone tissue. Histological analysis includes evaluation of inflammatory cell infiltrates, trabecular bone formation, and bone morphology. The results of this study are expected to improve understanding of the immunological response associated with bone grafting procedures and may contribute to the development of more predictable regenerative treatment strategies in implant dentistry.

Interventions

Xenogeneic bone graft material used for bone regeneration procedures prior to dental implant placement during sinus lift surgery.

PROCEDUREAllogeneic Bone Graft

Allogeneic bone graft material obtained from a human tissue bank and used for bone augmentation procedures prior to dental implant placement.

PROCEDURELow-Level Laser Therapy

Postoperative photobiomodulation performed using a diode laser device (Smart M, Lasotronix, Poland). Four irradiation sessions were performed with an energy density of 4 J/cm2 for approximately 20 seconds per session.

Sponsors

Medical Innovation Center Wroclaw
Lead SponsorOTHER
Wrocław Medical University
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Histological and radiological evaluations were performed by investigators who were not involved in the surgical procedures and were blinded to group allocation.

Intervention model description

Participants undergoing bone regeneration procedures prior to implant therapy were assigned to receive either xenogeneic or allogeneic bone graft material. Additionally, a subgroup of participants received adjunctive photobiomodulation using low-level laser therapy (LLLT) during the postoperative period.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18 years or older * Patients requiring bone augmentation procedures prior to dental implant placement * Insufficient alveolar bone volume requiring regenerative treatment * Good general health condition * Ability and willingness to provide written informed consent

Exclusion criteria

* Systemic diseases affecting bone healing * Active oral infections or inflammatory conditions at the surgical site * Use of medications affecting bone metabolism (e.g., bisphosphonates) * Pregnancy or breastfeeding * Heavy smoking * Previous bone grafting procedures in the planned surgical site

Design outcomes

Primary

MeasureTime frameDescription
Change in Anti-HLA Antibody Levels Measured by Luminex Single-Antigen Bead AssayBaseline and 6 months after bone augmentationChange in serum anti-HLA antibody levels measured by Luminex single-antigen bead assay Assessment of changes in serum anti-human leukocyte antigen (anti-HLA) antibody levels following bone regeneration procedures using xenogeneic or allogeneic graft materials. Antibody levels will be measured using a Luminex single-antigen bead immunoassay.

Secondary

MeasureTime frameDescription
Radiographic bone regeneration in vertical bone height6 months after bone augmentationRadiographic bone regeneration assessed by cone-beam computed tomography (CBCT) Evaluation of bone regeneration in the augmented area using CBCT imaging, including vertical bone height gain (in mm)
Histomorphometric Evaluation of Regenerated Bone from Core Biopsies6 months after augmentation during implant placementHistomorphometric analysis of regenerated bone from core biopsies Histomorphometric evaluation of bone core biopsies collected during implant placement to determine: percentage of newly formed bone percentage of connective tissue percentage of residual graft material
Bone Healing Parameters in Photobiomodulation vs Control Groups Assessed by CBCT and Histomorphometry6 months after bone augmentationBone regeneration parameters in photobiomodulation vs control groups assessed by CBCT and histomorphometry Comparison of bone regeneration parameters between groups receiving adjunctive low-level laser therapy (LLLT) and control groups using: CBCT radiographic measurements histomorphometric analysis of bone biopsies

Countries

Poland

Contacts

PRINCIPAL_INVESTIGATORPaweł Kubasiewicz-Ross, dr hab.

Department of Dental Surgery, Faculty of Dentistry, Wroclaw Medical University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026